Guest appearance

Thermaltake Elevates Gaming Rigs Nationwide with Smart BM3 and ToughPower GF A3 PSUs Available at Best Buy Retail Stores

Retrieved on: 
Wednesday, April 24, 2024
UVP, Connectivity, OCP, Smart, Safety, 3.0, ATX, A3, OVP, Environment, Best Buy, SCP, OPP, Intel, Noise, OTP, Gold, Guest appearance, GPU, Longevity, PSU, Video game

WALNUT, Calif., April 24, 2024 /PRNewswire-PRWeb/ -- Thermaltake USA, a leading provider of PC case, cooling, power supply, and desktop memory solutions, today announced the nationwide release of the Smart BM3 Bronze and ToughPower GF A3 Gold series power supplies at Best Buy stores. These cutting-edge products are designed to meet the needs of the most demanding gaming and graphic setups, offering power ratings from 650W to 1200W. Featuring full ATX 3.0 and PCIe Gen5 compliance and equipped with the revolutionary 12VHPWR connector, these power supplies are ready to support the most advanced graphics cards available on the market.

Key Points: 
  • WALNUT, Calif., April 24, 2024 /PRNewswire-PRWeb/ -- Thermaltake USA, a leading provider of PC case, cooling, power supply, and desktop memory solutions, today announced the nationwide release of the Smart BM3 Bronze and ToughPower GF A3 Gold series power supplies at Best Buy stores.
  • "Best Buy has been a pivotal partner for Thermaltake as we strive towards sustainability.
  • "Best Buy has been a pivotal partner for Thermaltake as we strive towards sustainability.
  • ToughPower GF A3 Gold series power supplies, offered in 1200W, 1050W, and 850W models, are expertly engineered to meet the demands of next-generation PCs.

The Inner Circle Acknowledges, J. Carl Haggerty as a Top Pinnacle Professional for his contributions to the field of Brand Strategy Conservancy

Retrieved on: 
Wednesday, October 11, 2023
Guest appearance, USVI, Cat, Hudson River, Haggerty, Organization, Education, Love, Growth, Cornell University, Philosophy, Athlete, Inner circle, Ithaca College

YONKERS, N.Y., Oct. 11, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, J. Carl Haggerty is acknowledged as a Top Pinnacle Professional for his contributions to the field of Brand Strategy Conservancy.

Key Points: 
  • YONKERS, N.Y., Oct. 11, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, J. Carl Haggerty is acknowledged as a Top Pinnacle Professional for his contributions to the field of Brand Strategy Conservancy.
  • Mr. Haggerty currently works at Prive International where he is involved in various companies offering a range of products and services.
  • He specializes in developing brand strategies for clients, while Quantum International focuses on business management and connections, and NetRep, LLC facilitates connections and contracts at the highest level.
  • He enjoys being surrounded by his wife, two children, six grandchildren, and three cats n in his home in Yonkers, overlooking the Hudson River.

Sonny's BBQ Introduces Limited Time Only Candied Bacon Big Deal Lineup

Retrieved on: 
Monday, June 12, 2023
BBQ, Hoisin sauce, Friends, Sonny, Lettuce, Thought, Water, Tea, Guest appearance, Chipotle, Family, Mouth, Fast food, Amusement park

ORLANDO, Fla., June 12, 2023 /PRNewswire/ -- Sonny's BBQ, the industry-leading BBQ restaurant rooted in quality food and spreading kindness, today announced the biggest Big Deal Lineup menu change of the year with the introduction of chipotle candied bacon to the menu. Starting June 12, guests can order three new sandwiches including the Candied Bacon Burger, Candied Bacon Chicken Sandwich and Fried Green Tomato BLT for a limited time at their favorite Sonny's location. The summertime addition emphasizes the brand's commitment to offering guests variety while maintaining quality products at a value.

Key Points: 
  • Starting June 12, guests can order three new sandwiches including the Candied Bacon Burger, Candied Bacon Chicken Sandwich and Fried Green Tomato BLT for a limited time at their favorite Sonny's location.
  • So, that's what we did with our limited release Big Deal Lineup featuring chipotle candied bacon on top of classic sandwiches.
  • The new sandwiches include:
    The Candied Bacon Burger Big Deal with a certified Angus beef burger topped with chipotle candied bacon, American cheese, onion straws and Sonny's signature Sizzlin' BBQ sauce.
  • The Candied Bacon Chicken Sandwich Big Deal with a grilled chicken breast topped with chipotle candied bacon, Swiss cheese, onion straws and a drizzle of Sonny's mustard BBQ Sauce.

Suvoda 2022 Clinical Trials Surge 20% as it Expands Offerings to Include eConsent and eCOA

Retrieved on: 
Tuesday, January 17, 2023
Benchmark, ISR, Guest appearance, CTMS, Cros, CNS, Fruit, EPRO, JIT, Central nervous system, IRT, Translation, Patient, EDC, Data, Clinical data management, Clinical trial, Life, Pharmaceutical industry, Fine chemical, Warehouse

PHILADELPHIA, Jan. 17, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, surpassed 1,000 clinical trials in 2022 as study deployments surged nearly 20%, a strong indicator that the company's practical approach to innovation is being embraced by trial sponsors and CROs. Click to tweet.

Key Points: 
  • Suvoda's expanded clinical trial offerings in 2022 were designed organically to work seamlessly on a single platform, and include important features that sponsors need to quickly and reliably conduct trials.
  • New products and features include:
    eConsent – Suvoda eConsent, which became generally available in May, offers a simplified approach to digitizing the consent management process.
  • Electronic clinical outcome assessment (eCOA) – Suvoda eCOA seeks to tackle inefficiencies common in traditional eCOA products, such as gaps in overall delivery and execution quality, time-consuming translations and localization processes, and logistics related to device management.
  • "Trial sponsors and CROs have told us they need new approaches to global clinical trials with patients at the center of the studies, and we have listened," said Jagath Wanninayake, CEO of Suvoda.

Sanofi Selects THREAD as Global Decentralized Clinical Trials Provider

Retrieved on: 
Tuesday, January 17, 2023
Guest appearance, DCTS, Center for Sustainable Global Enterprise, Heart, Senior, Patient, Research, IPP, Commitment, Pharmaceutical industry, Sanofi

CARY, N.C., Jan. 17, 2023 /PRNewswire/ -- THREAD, the leading technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), announced today its five-year collaboration with innovative global health care company, Sanofi. THREAD will serve as the sole provider of unified decentralized clinical trials (DCTs) and electronic clinical outcome assessments (eCOA) technology for Sanofi's Integrated Patient Platform (IPP), part of its global Act4Patients program.

Key Points: 
  • Collaboration to Support Sanofi's Commitment to Building Patient-Centric, Modern Clinical Research Infrastructure across the Global Enterprise
    CARY, N.C., Jan. 17, 2023 /PRNewswire/ -- THREAD , the leading technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), announced today its five-year collaboration with innovative global health care company, Sanofi .
  • THREAD will serve as the sole provider of unified decentralized clinical trials (DCTs) and electronic clinical outcome assessments (eCOA) technology for Sanofi's Integrated Patient Platform (IPP), part of its global Act4Patients program.
  • THREAD's technology and services enable flexible, patient-centric, and inclusive clinical trials by providing an interconnected and uniform digital experience for patients, investigators, and sites across their clinical trials journey.
  • Learn more about how THREAD is supporting a patient-centric, modern clinical research infrastructure across Sanofi's global enterprise at threadresearch.com .

Sanofi Selects THREAD as Global Decentralized Clinical Trials Provider

Retrieved on: 
Tuesday, January 17, 2023
Guest appearance, DCTS, Center for Sustainable Global Enterprise, Heart, Senior, Patient, Research, IPP, Commitment, Pharmaceutical industry, Sanofi

CARY, N.C., Jan. 17, 2023 /PRNewswire/ -- THREAD, the leading technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), announced today its five-year collaboration with innovative global health care company, Sanofi. THREAD will serve as the sole provider of unified decentralized clinical trials (DCTs) and electronic clinical outcome assessments (eCOA) technology for Sanofi's Integrated Patient Platform (IPP), part of its global Act4Patients program.

Key Points: 
  • Collaboration to Support Sanofi's Commitment to Building Patient-Centric, Modern Clinical Research Infrastructure across the Global Enterprise
    CARY, N.C., Jan. 17, 2023 /PRNewswire/ -- THREAD , the leading technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), announced today its five-year collaboration with innovative global health care company, Sanofi .
  • THREAD will serve as the sole provider of unified decentralized clinical trials (DCTs) and electronic clinical outcome assessments (eCOA) technology for Sanofi's Integrated Patient Platform (IPP), part of its global Act4Patients program.
  • THREAD's technology and services enable flexible, patient-centric, and inclusive clinical trials by providing an interconnected and uniform digital experience for patients, investigators, and sites across their clinical trials journey.
  • Learn more about how THREAD is supporting a patient-centric, modern clinical research infrastructure across Sanofi's global enterprise at threadresearch.com .

Suvoda 2022 Clinical Trials Surge 20% as it Expands Offerings to Include eConsent and eCOA

Retrieved on: 
Tuesday, January 17, 2023
Benchmark, ISR, Guest appearance, CTMS, Cros, CNS, Fruit, EPRO, JIT, Central nervous system, IRT, Translation, Patient, EDC, Data, Clinical data management, Clinical trial, Life, Pharmaceutical industry, Fine chemical, Warehouse

PHILADELPHIA, Jan. 17, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, surpassed 1,000 clinical trials in 2022 as study deployments surged nearly 20%, a strong indicator that the company's practical approach to innovation is being embraced by trial sponsors and CROs. Click to tweet.

Key Points: 
  • Suvoda's expanded clinical trial offerings in 2022 were designed organically to work seamlessly on a single platform, and include important features that sponsors need to quickly and reliably conduct trials.
  • New products and features include:
    eConsent –Suvoda eConsent, which became generally available in May, offers a simplified approach to digitizing the consent management process.
  • Electronic clinical outcome assessment (eCOA) --Suvoda eCOA seeks to tackle inefficiencies common in traditional eCOA products, such as gaps in overall delivery and execution quality, time-consuming translations and localization processes, and logistics related to device management.
  • "Trial sponsors and CROs have told us they need new approaches to global clinical trials with patients at the center of the studies, and we have listened," said Jagath Wanninayake, CEO of Suvoda.

Global Interactive Response Technology (IRT) Benchmarking & Market Dynamics Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Monday, January 16, 2023
Health, Biotechnology, Benchmarking, Cros, Guest appearance, Perception, Randomization, IRT, EDC, CTMS, Pulse, Fine chemical, Cryptocurrency, Arbutus Biopharma

The "IRT Benchmarking & Market Dynamics (4th Ed)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "IRT Benchmarking & Market Dynamics (4th Ed)" report has been added to ResearchAndMarkets.com's offering.
  • The Interactive Response Technology (IRT) space, also sometimes called Randomization and Trial Supply Management (RTSM), has continued to evolve since 2014.
  • There are few dedicated IRT providers left among the market leaders, and customers continue to value integration with EDC, CTMS, eCOA, and other technologies above all else.
  • The clinical technology industry continues to see a lot of change, including mergers, acquisitions, and spin-offs among leaders in the space.

eClinical Solutions Market Report 2022: Rising Use of Software Solutions in Clinical Trials Boosts Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 12, 2023
Health, Health Technology, Guest appearance, Use, Cros, Clinical trial, Safety, Human services, Projection, Growth, Region, Patient, Research, Clinical data management, Data analysis, Medicine, III, USD, United States Department of Health and Human Services, Health, Pharmaceutical industry, Software

Expansion of biopharmaceutical and pharmaceutical firms' research and development efforts and rising use of software solutions in clinical trials are factors contributing to the market growth.

Key Points: 
  • Expansion of biopharmaceutical and pharmaceutical firms' research and development efforts and rising use of software solutions in clinical trials are factors contributing to the market growth.
  • Additionally, strict regulatory framework for clinical trials and the increasing demand for safety monitoring and increasing Use of Software in Clinical Trials.
  • Strict regulatory framework for clinical trials and the increasing demand for safety monitoring is expected to propel the market growth.
  • One of the main growth drivers of the market for eClinical solutions is the soaring demand for software solutions for clinical trials by pharma and biopharma companies.

Datacubed Health, a Sterling Partners Portfolio Company, Achieves Impressive 150% YOY Growth

Retrieved on: 
Tuesday, December 20, 2022
Clinical trial, Translation, Rigidity, Televisit, COVID-19, Sterling, Health, EPRO, Cros, Patient engagement in Canada, Growth, Clinical data management, Entrepreneurship, Investment, Guest appearance, Datacube Inc., Medicine, Fine chemical, Pharmaceutical industry

Brooklyn, New York, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Datacubed Health (“Datacubed”), a digital health technology company that supports hybrid and decentralized clinical trials, and Sterling Partners (“Sterling”), a prominent investment management firm, announced December 20, 2022, substantial year-over-year growth.

Key Points: 
  • Brooklyn, New York, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Datacubed Health (“Datacubed”), a digital health technology company that supports hybrid and decentralized clinical trials, and Sterling Partners (“Sterling”), a prominent investment management firm, announced December 20, 2022, substantial year-over-year growth.
  • Following its initial investment in 2020, Sterling has continued to support Datacubed.
  • At its founding, Datacubed was rooted in behavioral science and offered a gamified ePRO solution designed to boost patient engagement.
  • Steven Taslitz, Co-Founder and Chairman of Sterling Partners, said, “We believe the industry is at an inflection point.